ATXS
Price
$4.66
Change
-$0.49 (-9.51%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
290.92M
33 days until earnings call
CMPX
Price
$1.46
Change
-$0.15 (-9.32%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
221.94M
36 days until earnings call
Ad is loading...

ATXS vs CMPX

Header iconATXS vs CMPX Comparison
Open Charts ATXS vs CMPXBanner chart's image
Astria Therapeutics
Price$4.66
Change-$0.49 (-9.51%)
Volume$1.09K
Capitalization290.92M
Compass Therapeutics
Price$1.46
Change-$0.15 (-9.32%)
Volume$11.62K
Capitalization221.94M
ATXS vs CMPX Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. CMPX commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and CMPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (ATXS: $5.15 vs. CMPX: $1.61)
Brand notoriety: ATXS and CMPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 92% vs. CMPX: 117%
Market capitalization -- ATXS: $290.92M vs. CMPX: $221.94M
ATXS [@Biotechnology] is valued at $290.92M. CMPX’s [@Biotechnology] market capitalization is $221.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCMPX’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • CMPX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATXS and CMPX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while CMPX’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 4 bearish.
  • CMPX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than CMPX.

Price Growth

ATXS (@Biotechnology) experienced а -15.02% price change this week, while CMPX (@Biotechnology) price change was -23.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

ATXS is expected to report earnings on May 08, 2025.

CMPX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($291M) has a higher market cap than CMPX($222M). CMPX YTD gains are higher at: 10.690 vs. ATXS (-42.394). CMPX has higher annual earnings (EBITDA): -54.87M vs. ATXS (-111.56M). ATXS has more cash in the bank: 328M vs. CMPX (127M). ATXS has less debt than CMPX: ATXS (5.35M) vs CMPX (6.63M). CMPX has higher revenues than ATXS: CMPX (850K) vs ATXS (0).
ATXSCMPXATXS / CMPX
Capitalization291M222M131%
EBITDA-111.56M-54.87M203%
Gain YTD-42.39410.690-397%
P/E RatioN/AN/A-
Revenue0850K-
Total Cash328M127M258%
Total Debt5.35M6.63M81%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCMPX
RSI
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
81%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
87%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 5 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
87%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-6.70%
KYMR - ATXS
49%
Loosely correlated
-10.13%
DNLI - ATXS
48%
Loosely correlated
-6.91%
CRNX - ATXS
47%
Loosely correlated
-8.03%
TRDA - ATXS
47%
Loosely correlated
-8.86%
ABOS - ATXS
46%
Loosely correlated
-8.52%
More